Increased IL-33, which is a member of the IL-1 cytokine family, points towards a mucosal barrier leakage in ME/CFS patients without immunodeficiencies, as it acts as an alarmin to provide acute initial protection [31]. This evidence concerns the gene IL33 and myalgic encephalomeyelitis/chronic fatigue syndrome.